Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — A collaboratively designed nurse-driven supine trial protocol for prone, intubated patients ...
Drawing from research on sepsis and complement biology, they developed the monoclonal antibody vilobelimab to block overactive inflammatory responses in patients with severe inflammatory diseases ...
Edesa Biotech ((EDSA)), Inflarx N.V. ((IFRX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and ...
Edesa Biotech ((EDSA)), Inflarx N.V. ((IFRX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results